SA4503 8-Week Study in Major Depressive Disorder (MDD)

NCT00551109 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: placebo
DRUG: SA4503 Low
DRUG: SA4503 High

Sponsor

M's Science Corporation